Savaria Co. (TSE:SIS – Get Free Report) Director Jean-Louis Chapdelaine sold 25,000 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of C$27.73, for a total transaction of C$693,250.00. Following the completion of the sale, the director owned 100,000 shares in the company, valued at C$2,773,000. This represents a 20.00% decrease in their ownership of the stock.
Savaria Stock Performance
Shares of TSE:SIS opened at C$27.99 on Tuesday. The company has a market capitalization of C$2.01 billion, a price-to-earnings ratio of 25.45, a P/E/G ratio of 42.72 and a beta of 0.97. The firm’s 50 day simple moving average is C$27.64 and its 200 day simple moving average is C$24.87. The company has a debt-to-equity ratio of 31.42, a current ratio of 1.71 and a quick ratio of 0.91. Savaria Co. has a fifty-two week low of C$18.71 and a fifty-two week high of C$30.62.
Savaria (TSE:SIS – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported C$0.31 earnings per share for the quarter. The business had revenue of C$235.55 million for the quarter. Savaria had a net margin of 8.50% and a return on equity of 12.41%. As a group, sell-side analysts forecast that Savaria Co. will post 1.2048518 earnings per share for the current year.
Analysts Set New Price Targets
Read Our Latest Research Report on SIS
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
